Invigor Medical vs Breeze Meds
Two GLP-1 desks, one scoreboard. We put Invigor Medical and Breeze Meds head-to-head on the published Brief Score — the same six factors, scored the same way.
Invigor Medical
The verdict
Invigor Medical takes this head-to-head.
Invigor Medical scores 88 to 76 on our six-factor Brief Score — An established telehealth pharmacy with a broad metabolic and hormone catalog and a steady price line.
That doesn't make Breeze Meds a bad call — it's best for readers starting at a low dose who want nothing charged until a provider has approved them. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Invigor Medical | Breeze Meds | |
|---|---|---|
| Brief Score | 88/100 (B+) | 76/100 (C) |
| Semaglutide | $199/mo | From $199/mo injectable · $299/mo oral (lowest dose) |
| Tirzepatide | $339/mo | From $399/mo injectable · $399/mo oral (lowest dose) |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Stableprice stable |
Invigor Medical: Long-running operator; mid-market pricing unchanged this cycle.
Breeze Meds: ⚠ Every published figure is quoted at the LOWEST dose — the funnel says higher doses may cost more, so these are floors.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.